BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31395950)

  • 1. Machine learning-based prediction of breast cancer growth rate in vivo.
    Bhattarai S; Klimov S; Aleskandarany MA; Burrell H; Wormall A; Green AR; Rida P; Ellis IO; Osan RM; Rakha EA; Aneja R
    Br J Cancer; 2019 Sep; 121(6):497-504. PubMed ID: 31395950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.
    Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA
    Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of digital breast tomosynthesis and full-field digital mammography with new reconstruction and new processing for dose reduction.
    Endo T; Morita T; Oiwa M; Suda N; Sato Y; Ichihara S; Shiraiwa M; Yoshikawa K; Horiba T; Ogawa H; Hayashi Y; Sendai T; Arai T
    Breast Cancer; 2018 Mar; 25(2):159-166. PubMed ID: 28956298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. St Gallen molecular subtypes in screening-detected and symptomatic breast cancer in a prospective cohort with long-term follow-up.
    Falck AK; Röme A; Fernö M; Olsson H; Chebil G; Bendahl PO; Rydén L
    Br J Surg; 2016 Apr; 103(5):513-23. PubMed ID: 26856820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of screen-detected cancers following concordant or discordant recalls at blinded double reading in biennial digital screening mammography.
    Coolen AMP; Lameijer JRC; Voogd AC; Louwman MWJ; Strobbe LJ; Tjan-Heijnen VCG; Duijm LEM
    Eur Radiol; 2019 Jan; 29(1):337-344. PubMed ID: 29943181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of breast cancer risk using a machine learning approach embedded with a locality preserving projection algorithm.
    Heidari M; Khuzani AZ; Hollingsworth AB; Danala G; Mirniaharikandehei S; Qiu Y; Liu H; Zheng B
    Phys Med Biol; 2018 Jan; 63(3):035020. PubMed ID: 29239858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast screening and breast cancer survival in Aboriginal and Torres Strait Islander women of Australia.
    Roder D; Webster F; Zorbas H; Sinclair S
    Asian Pac J Cancer Prev; 2012; 13(1):147-55. PubMed ID: 22502658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection method and breast carcinoma histology.
    Newcomer LM; Newcomb PA; Trentham-Dietz A; Storer BE; Yasui Y; Daling JR; Potter JD
    Cancer; 2002 Aug; 95(3):470-7. PubMed ID: 12209738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
    van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
    Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for stage IV breast cancer at the time of presentation in Turkey.
    Uyeturk U; Tatli AM; Gucuk S; Oksuzoglu B; Ulas A; Avci N; Ozbay MF; Gunduz S; Akinci MB; Salim DK; Sonmez OU; Akdag F; Ergenc H
    Asian Pac J Cancer Prev; 2013; 14(12):7445-9. PubMed ID: 24460317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer-aided detection system applied to full-field digital mammograms.
    Bolivar AV; Gomez SS; Merino P; Alonso-Bartolomé P; Garcia EO; Cacho PM; Hoffmeister JW
    Acta Radiol; 2010 Dec; 51(10):1086-92. PubMed ID: 20883182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
    Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
    Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical management of lobular carcinoma from a national screening program: a retrospective analysis.
    Sharma SD; Barry M; O'Reilly EA; Kell MR
    Eur J Surg Oncol; 2015 Jan; 41(1):79-85. PubMed ID: 25441933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
    Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
    Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facility Mammography Volume in Relation to Breast Cancer Screening Outcomes.
    Onega T; Goldman LE; Walker RL; Miglioretti DL; Buist DS; Taplin S; Geller BM; Hill DA; Smith-Bindman R
    J Med Screen; 2016 Mar; 23(1):31-7. PubMed ID: 26265482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of frozen section analysis of sentinel lymph nodes for the detection of Asian breast cancer micrometastasis - experience from Pakistan.
    Hashmi AA; Faridi N; Khurshid A; Naqvi H; Malik B; Malik FR; Fida Z; Mujtuba S
    Asian Pac J Cancer Prev; 2013; 14(4):2657-62. PubMed ID: 23725191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 Years.
    Lourenco AP; Benson KL; Henderson MC; Silver M; Letsios E; Tran Q; Gordon KJ; Borman S; Corn C; Mulpuri R; Smith W; Alpers J; Costantini C; Rohatgi N; Yang R; Haythem A; Biren S; Morris M; Kass F; Reese DE
    Clin Breast Cancer; 2017 Nov; 17(7):516-525.e6. PubMed ID: 28624156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attending breast cancer screening alone does not explain the detection of tumours at an early stage.
    Ouédraogo S; Dabakuyo TS; Gentil J; Poillot ML; Dancourt V; Arveux P
    Eur J Cancer Prev; 2013 Mar; 22(2):103-11. PubMed ID: 22751208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of breast cancers detected in the Verona screening program following transition to digital breast tomosynthesis screening with cancers detected at digital mammography screening.
    Caumo F; Romanucci G; Hunter K; Zorzi M; Brunelli S; Macaskill P; Houssami N
    Breast Cancer Res Treat; 2018 Jul; 170(2):391-397. PubMed ID: 29557996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.